CSIMarket
 
Ardelyx Inc   (ARDX)
Other Ticker:  
 
 
Price: $8.1000 $0.07 0.872%
Day's High: $8.23 Week Perf: -4.59 %
Day's Low: $ 7.97 30 Day Perf: -12.72 %
Volume (M): 11,257 52 Wk High: $ 10.13
Volume (M$): $ 91,185 52 Wk Avg: $5.11
Open: $8.02 52 Wk Low: $3.16



 Market Capitalization (Millions $) 1,784
 Shares Outstanding (Millions) 220
 Employees -
 Revenues (TTM) (Millions $) 164
 Net Income (TTM) (Millions $) -32
 Cash Flow (TTM) (Millions $) -40
 Capital Exp. (TTM) (Millions $) 0

Ardelyx Inc
Ardelyx Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments for gastrointestinal and cardio-renal diseases. They are committed to providing improved options for patients suffering from chronic and debilitating conditions. Ardelyx's research and development efforts are centered around developing novel oral therapeutics targeting specific biological mechanisms within the gut to address unmet medical needs. Their aim is to develop effective and safe treatments that improve patient outcomes and quality of life.


   Company Address: 400 FIFTH AVE. WALTHAM 2451 MA
   Company Phone Number: 745-1700   Stock Exchange / Ticker: NASDAQ ARDX
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Employment Inducement Grants: A Viable Strategy in the Pharmaceutical Industry

Published Tue, Mar 12 2024 8:35 PM UTC

In a dynamic and competitive industry like pharmaceuticals, attracting and retaining top-notch talent is crucial for continued success. To this end, Ardelyx, Inc., a prominent biopharmaceutical company, recently announced the issuance of employment inducement grants to non-executive employees. These grants, consisting of stock options and restricted stock units (RSUs), serve...

Shares

Ardelyx Employs Stock Options and RSUs to Attract Top Talent, Driving Promising Growth in the Biopharmaceutical Industry

Published Wed, Dec 20 2023 1:00 PM UTC



WALTHAM, Mass., Dec. 20, 2023 - Ardelyx, Inc. (Nasdaq: ARDX), a leading biopharmaceutical company dedicated to discovering, developing, and commercializing innovative, first-in-class medicines to address significant unmet medical needs, continues to make waves in the industry. The company announced on December 18, 2023, that it had granted stock options and restric...

Shares

Ardelyx Employs Stock Options and RSUs to Rally Exceptional Talent in Pursuit of Medical Breakthroughs

Published Tue, Nov 21 2023 9:02 PM UTC

Ardelyx Employs Stock Options and RSUs to Enlist Top Talent, Intensifying the Quest for Medical Breakthroughs
WALTHAM, Mass., Nov. 21, 2023 ? Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative first-in-class medicines to address significant unmet medical needs, has announced the granting of stock...

Product Service News

Ardelyx Celebrates Dr. Geoffrey Block's Five Years of Service as He Steps Down from the Board of Directors

Published Mon, Nov 13 2023 9:02 PM UTC



WALTHAM, Mass., Nov. 13, 2023 - Ardelyx, Inc. (Nasdaq: ARDX), a renowned biopharmaceutical company committed to discovering, developing, and commercializing innovative, first-in-class medicines to address unmet medical needs, announced today the departure of Dr. Geoffrey Block from their esteemed Board of Directors. Having served Ardelyx for nearly five years, Dr. ...

Shares

Ardelyx Employs Stock Options and RSUs to Enlist Top Talent, Intensifying the Quest for Medical Breakthroughs

Published Thu, Sep 7 2023 12:00 PM UTC



WALTHAM, Mass., Sept. 07, 2023 - Ardelyx, Inc. (Nasdaq: ARDX), a leading biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines that address critical unmet medical needs, recently announced the granting of valuable stock options and restricted stock units (RSUs) to new non-executive employees. These inducements show...






 

Ardelyx Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Ardelyx Inc does not provide revenue guidance.

Earnings Outlook
Ardelyx Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com